ロード中...
Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens
Hypersensitivity reactions (HSRs) to paclitaxel are frequently encountered in patients receiving this antitumour drug. Administration of histamine H1- and H2-receptor antagonists and corticosteroids has been shown to reduce significantly the risk of developing an HSR in patients receiving taxanes. I...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2004
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2409560/ https://ncbi.nlm.nih.gov/pubmed/14974481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601303 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|